Therapeutic concentration of morphine reduces oxidative stress in glioma cell line

Detalhes bibliográficos
Autor(a) principal: ALMEIDA, Mauro Brito de
Data de Publicação: 2014
Outros Autores: MALAQUIAS, Allan Costa, NASCIMENTO, José Luiz Martins do, OLIVEIRA, Karen Renata Matos, SILVA, Anderson Manoel Herculano Oliveira da, CRESPO LÓPEZ, Maria Elena
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UFPA
Texto Completo: http://repositorio.ufpa.br/jspui/handle/2011/6630
Resumo: Morphine is a potent analgesic opioid used extensively for pain treatment. During the last decade, global consumption grew more than 4-fold. However, molecular mechanisms elicited by morphine are not totally understood. Thus, a growing literature indicates that there are additional actions to the analgesic effect. Previous studies about morphine and oxidative stress are controversial and used concentrations outside the range of clinical practice. Therefore, in this study, we hypothesized that a therapeutic concentration of morphine (1 μM) would show a protective effect in a traditional model of oxidative stress. We exposed the C6 glioma cell line to hydrogen peroxide (H2O2) and/or morphine for 24 h and evaluated cell viability, lipid peroxidation, and levels of sulfhydryl groups (an indicator of the redox state of the cell). Morphine did not prevent the decrease in cell viability provoked by H2O2) but partially prevented lipid peroxidation caused by 0.0025% H2O2) (a concentration allowing more than 90% cell viability). Interestingly, this opioid did not alter the increased levels of sulfhydryl groups produced by exposure to 0.0025% H2O2), opening the possibility that alternative molecular mechanisms (a direct scavenging activity or the inhibition of NAPDH oxidase) may explain the protective effect registered in the lipid peroxidation assay. Our results demonstrate, for the first time, that morphine in usual analgesic doses may contribute to minimizing oxidative stress in cells of glial origin. This study supports the importance of employing concentrations similar to those used in clinical practice for a better approximation between experimental models and the clinical setting.
id UFPA_1da50fd0004d19947612dedd01a10fb4
oai_identifier_str oai:repositorio.ufpa.br:2011/6630
network_acronym_str UFPA
network_name_str Repositório Institucional da UFPA
repository_id_str 2123
spelling 2015-05-08T14:09:59Z2015-05-08T14:09:59Z2014-05ALMEIDA, M. B. et al. Therapeutic concentration of morphine reduces oxidative stress in glioma cell line. Brazilian Journal of Medical and Biological Research, Ribeirão Preto, v. 47, n. 5, p. 398-402, maio 2014. Disponível em: <http://www.scielo.br/pdf/bjmbr/v47n5/1414-431X-bjmbr-1414-431X20143697.pdf>. Acesso em: 23 abr. 2015. <http://dx.doi.org/10.1590/1414-431X20143697>.1414-431Xhttp://repositorio.ufpa.br/jspui/handle/2011/6630Morphine is a potent analgesic opioid used extensively for pain treatment. During the last decade, global consumption grew more than 4-fold. However, molecular mechanisms elicited by morphine are not totally understood. Thus, a growing literature indicates that there are additional actions to the analgesic effect. Previous studies about morphine and oxidative stress are controversial and used concentrations outside the range of clinical practice. Therefore, in this study, we hypothesized that a therapeutic concentration of morphine (1 μM) would show a protective effect in a traditional model of oxidative stress. We exposed the C6 glioma cell line to hydrogen peroxide (H2O2) and/or morphine for 24 h and evaluated cell viability, lipid peroxidation, and levels of sulfhydryl groups (an indicator of the redox state of the cell). Morphine did not prevent the decrease in cell viability provoked by H2O2) but partially prevented lipid peroxidation caused by 0.0025% H2O2) (a concentration allowing more than 90% cell viability). Interestingly, this opioid did not alter the increased levels of sulfhydryl groups produced by exposure to 0.0025% H2O2), opening the possibility that alternative molecular mechanisms (a direct scavenging activity or the inhibition of NAPDH oxidase) may explain the protective effect registered in the lipid peroxidation assay. Our results demonstrate, for the first time, that morphine in usual analgesic doses may contribute to minimizing oxidative stress in cells of glial origin. This study supports the importance of employing concentrations similar to those used in clinical practice for a better approximation between experimental models and the clinical setting.engMorfinaNeurogliaEstresse oxidativoPeróxido de hidrogênioPeroxidação de lipídeosAnalgésicos opioidesTerapêuticaTherapeutic concentration of morphine reduces oxidative stress in glioma cell lineinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleALMEIDA, Mauro Brito deMALAQUIAS, Allan CostaNASCIMENTO, José Luiz Martins doOLIVEIRA, Karen Renata MatosSILVA, Anderson Manoel Herculano Oliveira daCRESPO LÓPEZ, Maria Elenainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFPAinstname:Universidade Federal do Pará (UFPA)instacron:UFPACC-LICENSElicense_urllicense_urltext/plain; charset=utf-849http://repositorio.ufpa.br/oai/bitstream/2011/6630/2/license_url4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-822762http://repositorio.ufpa.br/oai/bitstream/2011/6630/3/license_text321e754e6058db75d1137df814352636MD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-822190http://repositorio.ufpa.br/oai/bitstream/2011/6630/4/license_rdf19e8a2b57ef43c09f4d7071d2153c97dMD54ORIGINALArtigo_TherapeuticConcentrationMorphine.pdfArtigo_TherapeuticConcentrationMorphine.pdfapplication/pdf226366http://repositorio.ufpa.br/oai/bitstream/2011/6630/1/Artigo_TherapeuticConcentrationMorphine.pdf29c95b20eac9a93ab7765c29205d8708MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81703http://repositorio.ufpa.br/oai/bitstream/2011/6630/5/license.txta12ee01655d4f43dacf016d5e6168febMD55TEXTArtigo_TherapeuticConcentrationMorphine.pdf.txtArtigo_TherapeuticConcentrationMorphine.pdf.txtExtracted texttext/plain24186http://repositorio.ufpa.br/oai/bitstream/2011/6630/6/Artigo_TherapeuticConcentrationMorphine.pdf.txtd6f5c92268ee9ec9e93decd909959dd5MD562011/66302018-01-10 13:13:59.29oai:repositorio.ufpa.br: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Repositório InstitucionalPUBhttp://repositorio.ufpa.br/oai/requestriufpabc@ufpa.bropendoar:21232018-01-10T16:13:59Repositório Institucional da UFPA - Universidade Federal do Pará (UFPA)false
dc.title.pt_BR.fl_str_mv Therapeutic concentration of morphine reduces oxidative stress in glioma cell line
title Therapeutic concentration of morphine reduces oxidative stress in glioma cell line
spellingShingle Therapeutic concentration of morphine reduces oxidative stress in glioma cell line
ALMEIDA, Mauro Brito de
Morfina
Neuroglia
Estresse oxidativo
Peróxido de hidrogênio
Peroxidação de lipídeos
Analgésicos opioides
Terapêutica
title_short Therapeutic concentration of morphine reduces oxidative stress in glioma cell line
title_full Therapeutic concentration of morphine reduces oxidative stress in glioma cell line
title_fullStr Therapeutic concentration of morphine reduces oxidative stress in glioma cell line
title_full_unstemmed Therapeutic concentration of morphine reduces oxidative stress in glioma cell line
title_sort Therapeutic concentration of morphine reduces oxidative stress in glioma cell line
author ALMEIDA, Mauro Brito de
author_facet ALMEIDA, Mauro Brito de
MALAQUIAS, Allan Costa
NASCIMENTO, José Luiz Martins do
OLIVEIRA, Karen Renata Matos
SILVA, Anderson Manoel Herculano Oliveira da
CRESPO LÓPEZ, Maria Elena
author_role author
author2 MALAQUIAS, Allan Costa
NASCIMENTO, José Luiz Martins do
OLIVEIRA, Karen Renata Matos
SILVA, Anderson Manoel Herculano Oliveira da
CRESPO LÓPEZ, Maria Elena
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv ALMEIDA, Mauro Brito de
MALAQUIAS, Allan Costa
NASCIMENTO, José Luiz Martins do
OLIVEIRA, Karen Renata Matos
SILVA, Anderson Manoel Herculano Oliveira da
CRESPO LÓPEZ, Maria Elena
dc.subject.por.fl_str_mv Morfina
Neuroglia
Estresse oxidativo
Peróxido de hidrogênio
Peroxidação de lipídeos
Analgésicos opioides
Terapêutica
topic Morfina
Neuroglia
Estresse oxidativo
Peróxido de hidrogênio
Peroxidação de lipídeos
Analgésicos opioides
Terapêutica
description Morphine is a potent analgesic opioid used extensively for pain treatment. During the last decade, global consumption grew more than 4-fold. However, molecular mechanisms elicited by morphine are not totally understood. Thus, a growing literature indicates that there are additional actions to the analgesic effect. Previous studies about morphine and oxidative stress are controversial and used concentrations outside the range of clinical practice. Therefore, in this study, we hypothesized that a therapeutic concentration of morphine (1 μM) would show a protective effect in a traditional model of oxidative stress. We exposed the C6 glioma cell line to hydrogen peroxide (H2O2) and/or morphine for 24 h and evaluated cell viability, lipid peroxidation, and levels of sulfhydryl groups (an indicator of the redox state of the cell). Morphine did not prevent the decrease in cell viability provoked by H2O2) but partially prevented lipid peroxidation caused by 0.0025% H2O2) (a concentration allowing more than 90% cell viability). Interestingly, this opioid did not alter the increased levels of sulfhydryl groups produced by exposure to 0.0025% H2O2), opening the possibility that alternative molecular mechanisms (a direct scavenging activity or the inhibition of NAPDH oxidase) may explain the protective effect registered in the lipid peroxidation assay. Our results demonstrate, for the first time, that morphine in usual analgesic doses may contribute to minimizing oxidative stress in cells of glial origin. This study supports the importance of employing concentrations similar to those used in clinical practice for a better approximation between experimental models and the clinical setting.
publishDate 2014
dc.date.issued.fl_str_mv 2014-05
dc.date.accessioned.fl_str_mv 2015-05-08T14:09:59Z
dc.date.available.fl_str_mv 2015-05-08T14:09:59Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv ALMEIDA, M. B. et al. Therapeutic concentration of morphine reduces oxidative stress in glioma cell line. Brazilian Journal of Medical and Biological Research, Ribeirão Preto, v. 47, n. 5, p. 398-402, maio 2014. Disponível em: <http://www.scielo.br/pdf/bjmbr/v47n5/1414-431X-bjmbr-1414-431X20143697.pdf>. Acesso em: 23 abr. 2015. <http://dx.doi.org/10.1590/1414-431X20143697>.
dc.identifier.uri.fl_str_mv http://repositorio.ufpa.br/jspui/handle/2011/6630
dc.identifier.issn.none.fl_str_mv 1414-431X
identifier_str_mv ALMEIDA, M. B. et al. Therapeutic concentration of morphine reduces oxidative stress in glioma cell line. Brazilian Journal of Medical and Biological Research, Ribeirão Preto, v. 47, n. 5, p. 398-402, maio 2014. Disponível em: <http://www.scielo.br/pdf/bjmbr/v47n5/1414-431X-bjmbr-1414-431X20143697.pdf>. Acesso em: 23 abr. 2015. <http://dx.doi.org/10.1590/1414-431X20143697>.
1414-431X
url http://repositorio.ufpa.br/jspui/handle/2011/6630
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFPA
instname:Universidade Federal do Pará (UFPA)
instacron:UFPA
instname_str Universidade Federal do Pará (UFPA)
instacron_str UFPA
institution UFPA
reponame_str Repositório Institucional da UFPA
collection Repositório Institucional da UFPA
bitstream.url.fl_str_mv http://repositorio.ufpa.br/oai/bitstream/2011/6630/2/license_url
http://repositorio.ufpa.br/oai/bitstream/2011/6630/3/license_text
http://repositorio.ufpa.br/oai/bitstream/2011/6630/4/license_rdf
http://repositorio.ufpa.br/oai/bitstream/2011/6630/1/Artigo_TherapeuticConcentrationMorphine.pdf
http://repositorio.ufpa.br/oai/bitstream/2011/6630/5/license.txt
http://repositorio.ufpa.br/oai/bitstream/2011/6630/6/Artigo_TherapeuticConcentrationMorphine.pdf.txt
bitstream.checksum.fl_str_mv 4afdbb8c545fd630ea7db775da747b2f
321e754e6058db75d1137df814352636
19e8a2b57ef43c09f4d7071d2153c97d
29c95b20eac9a93ab7765c29205d8708
a12ee01655d4f43dacf016d5e6168feb
d6f5c92268ee9ec9e93decd909959dd5
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFPA - Universidade Federal do Pará (UFPA)
repository.mail.fl_str_mv riufpabc@ufpa.br
_version_ 1801771852890112000